The global rheumatoid arthritis market is growing at a significant CAGR of around 5.2% during the forecast period (2019-2025). Rheumatoid arthritis is a chronic, autoimmune, systemic inflammatory condition characterized by joint swelling, stiffness, pain, joint destruction and disability. Rheumatoid arthritis can also affect some other tissues across the body, which can cause problems in organs, such as the heart, lungs, and eyes. Some of the major factors that causes rheumatoid arthritis are sedentary lifestyle, which includes smoking, physical inactivity, leading to obesity. The urbanization and the fast-moving lifestyle have increased the sedentary lifestyle in developed and emerging economies. Therefore, the rheumatoid arthritis is expected to grow with the rise in sedentary lifestyle across the globe.

Get Free Sample Copy @https://www.omrglobal.com/request-sample/rheumatoid-arthritis-market

Moreover, there are several other pivotal factors that are driving the global rheumatoid arthritis market include the rising prevalence of diabetes. According to the International Diabetes Federation (IDF), the prevalence of diabetes across the globe is expected to reach 642 million in 2040, up from 415 million in 2015. The rapidly growing prevalence of diabetes accounted for around 12% of the global healthcare expenditure, around $673 billion in 2015, and this expenditure is projected to reach $802 billion by 2040. Such large prevalence of diabetes increases the risk of rheumatoid arthritis. According to the Arthritis Foundation, around half of adults having diabetes also have rheumatoid arthritis. This, in turn, is offering growth to the global rheumatoid arthritis market. However, the high cost of biologics is a major factor that restraints the growth of the global rheumatoid arthritis market.

Browse for Full Report Description@https://www.omrglobal.com/industry-reports/rheumatoid-arthritis-market

Market Segmentation

Global Rheumatoid Arthritis Market by Treatment

Medications

Nonsteroidal anti-inflammatory drugs (NSAIDs)
Disease-modifying anti-rheumatic drugs (DMARDs)
Biologics
Steroidal Medications
Surgery
Regional Analysis

North America
United States
Canada
Europe

UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific

China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles

AbbVie Inc.
Allergan PLC
Amgen Inc.
Anika Therapeutics, Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Biogen Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Co.
Celltrion Healthcare Co.,Ltd.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi SA
Swedish Orphan Biovitrum AB (SOBI)
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
UCB S.A.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rheumatoid-arthritis-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404